Abzu

Abzu provides AI tools designed specifically for pharmaceutical research and development. The platform focuses on creating explainable artificial intelligence that researchers can understand and trust, rather than treating AI as a black box. This matters in pharma because regulatory bodies and research teams need to comprehend why an AI system makes particular recommendations about drug candidates, molecular structures, or experimental outcomes. The tool helps scientists analyse complex biological data, identify promising compounds, and predict how potential drugs might behave. By combining machine learning with transparency features, Abzu aims to speed up early-stage drug discovery whilst maintaining the scientific rigour that regulatory approval requires. Abzu operates on a freemium model, allowing researchers to explore basic functionality before committing to a paid plan for more advanced capabilities.